A private, family-owned company based in Switzerland and parent company of a group that consists of Life Sciences Division (Debiopharm) & Asset Diversification Division, revolving around 6 main areas: - Direct Private Equity - Private Equity Funds (S.I.GN Partenaires SA) - Long-Term Participation - Help & Personal Care (Impact Healthcare SA) - Finance - Real Estate (Next Immobilier SA)